Saturday, October 31, 2026

EUR/JPY Bullish Momentum With A 1% Rise In The Last 10 Sessions

ViaNews Editorial Team

February 19, 2024

EUR/JPY Bullish Momentum With A 1% Rise In The Last 10 Sessions

(VIANEWS) - EUR/JPY (EURJPY) has been up by 1.11% for the last 10 sessions. At 13:06 EST on Monday, 19 February, EUR/JPY (EURJPY) is $161.86.

EUR/JPY's yearly highs and lows, it's 16.543% up from its 52-week low and 1.474% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was 0.07%, 0.01%, and 0.43%, respectively.

EUR/JPY's highest amplitude of average volatility was 0.13% (last week), 0.28% (last month), and 0.43% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/JPY's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy depreciates to near 150.00, Japan machinery orders improves. According to FXStreet on Monday, 19 February, "However, the USD/JPY pair soared on better-than-expected Producer Price Index (PPI) data from the United States on Friday. "
  • Usd/jpy forecast: US dollar continues to look strong against yen - 19 February 2024. According to DailyForex on Monday, 19 February, "The USD/JPY pair experienced a slight uptick early on Friday, rebounding from the key support level at 149.80 yen. ", "While short-term fluctuations may occur, the overall outlook suggests a continuation of the upward trend in the USD/JPY pair. "
  • Usd/jpy: any further gains could prompt renewed intervention in Japan – MUFG. According to FXStreet on Monday, 19 February, "Last week, USD/JPY moved back above the 150.00 level for the first time since November. ", "Just like on the previous occasions when USD/JPY reached these levels, we see momentum fading but broader US Dollar strength that could continue near term may mean intervention is required to stall the move."
  • Usd/jpy analysis: the uptrend remains dominant the uptrend remains dominant - 19 February 2024. According to DailyForex on Monday, 19 February, "According to performance, USD/JPY has now advanced to trade slightly above the 100-hour moving average line on the hourly chart. ", "The price of the USD/JPY pair rebounded last Friday from trend line support at around 149.85 to trade at around 150.26. "

More news about EUR/JPY (EURJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com